ACAAI 2021: Switch From Injectable Prophylaxis to Oral Berotralstat for Hereditary Angioedema Is Safe and Effective
Patient satisfaction levels increased with the switch to oral therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.